KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Receivables (2016 - 2025)

Historic Receivables for Exact Sciences (EXAS) over the last 12 years, with Q3 2025 value amounting to $337.9 million.

  • Exact Sciences' Receivables rose 789.86% to $337.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $337.9 million, marking a year-over-year increase of 789.86%. This contributed to the annual value of $274.9 million for FY2024, which is 1204.33% up from last year.
  • Exact Sciences' Receivables amounted to $337.9 million in Q3 2025, which was up 789.86% from $386.0 million recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Receivables registered a high of $386.0 million during Q2 2025, and its lowest value of $158.0 million during Q4 2022.
  • In the last 5 years, Exact Sciences' Receivables had a median value of $249.6 million in 2021 and averaged $251.4 million.
  • Its Receivables has fluctuated over the past 5 years, first surged by 8289.35% in 2021, then crashed by 2704.98% in 2022.
  • Over the past 5 years, Exact Sciences' Receivables (Quarter) stood at $216.6 million in 2021, then fell by 27.05% to $158.0 million in 2022, then surged by 55.23% to $245.3 million in 2023, then rose by 12.04% to $274.9 million in 2024, then increased by 22.91% to $337.9 million in 2025.
  • Its last three reported values are $337.9 million in Q3 2025, $386.0 million for Q2 2025, and $309.7 million during Q1 2025.